Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| GSK plc ADR | 5 | 0 | 0 | 0 | €39.40 | €49.33 | 25.196% |
| Humana Inc. | 23 | 0 | 0 | 0 | €329.30 | €381.44 | 15.833% |
| LivaNova plc | 12 | 0 | 0 | 0 | €44.80 | €66.49 | 48.420% |
| Icu Medical Inc. | 6 | 0 | 0 | 0 | €149.00 | €139.70 | -6.243% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €103.72 | €109.00 | 5.091% |
| Gilead Sciences Inc | 12 | 1 | 0 | 0 | €72.20 | €84.81 | 17.468% |
| Pfizer Inc. | 31 | 4 | 1 | 0 | €25.63 | €41.47 | 61.842% |
| Medtronic plc | 7 | 1 | 0 | 0 | €80.58 | €92.55 | 14.855% |
| Stryker Corp. | 31 | 0 | 1 | 0 | €325.70 | €340.93 | 4.676% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €95.54 | - | - |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 0 | 0 | €42.84 | €56.72 | 32.403% |
| Geron Corp. | 15 | 0 | 0 | 0 | €3.98 | €5.52 | 38.779% |
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €13.96 | - | - |
| Xencor Inc. | 16 | 0 | 0 | 0 | €15.50 | €31.38 | 102.454% |
| Paul Hartmann AG | 4 | 0 | 0 | 0 | €197.50 | - | - |
| Evotec SE | 10 | 1 | 3 | 0 | €6.19 | €7.00 | 13.086% |
| arGEN X BV | 1 | 0 | 0 | 0 | €465.60 | €470.00 | 0.945% |
| Bio-Techne Corp. | 9 | 0 | 0 | 0 | €67.50 | €75.80 | 12.301% |
| Healthequity Inc. | 2 | 0 | 0 | 0 | €71.50 | €82.25 | 15.035% |
| Charles River Labs Intl | 13 | 0 | 0 | 0 | €173.90 | €247.61 | 42.385% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €195.35 | - | - |
| Exelixis Inc. | 21 | 0 | 0 | 0 | €23.40 | €26.01 | 11.138% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €23.20 | €28.29 | 21.943% |
| Corcept Therapeutics Inc. | 17 | 0 | 0 | 0 | €31.91 | €36.87 | 15.537% |
| Dexcom Inc. | 26 | 0 | 0 | 0 | €65.54 | €121.12 | 84.808% |